{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:12:35Z","timestamp":1790993555260,"version":"4.1.0"},"reference-count":233,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijpx.2025.100397","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T05:06:56Z","timestamp":1757826416000},"page":"100397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["recent advances in the pathogenesis of vitiligo and the application of novel drug delivery systems in its treatment"],"prefix":"10.1016","volume":"10","author":[{"given":"Junjie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb0005","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1111\/jocd.14388","article-title":"The clinical and pathological effectiveness of microneedling and topical 5-fluorouracil in vitiligo treatment: An association with matrix metalloproteinase 2 immunohistochemical expression","volume":"21","author":"Abdou","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jdermsci.2020.10.014","article-title":"Serum levels of miRNA-21-5p in vitiligo patients and effects of miRNA-21-5p on SOX5, beta-catenin, CDK2 and MITF protein expression in normal human melanocytes","volume":"101","author":"Aguennouz","year":"2021","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ijpx.2025.100397_bb0015","article-title":"Current trends in polymer microneedle for transdermal drug delivery","volume":"587","author":"Al-Japairai","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"19","key":"10.1016\/j.ijpx.2025.100397_bb0020","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3390\/cells12192387","article-title":"Using a Topical Formulation of Vitamin D for the Treatment of Vitiligo: A Systematic Review","volume":"12","author":"Al-Smadi","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1566523217666170510151540","article-title":"Recent Advances in Skin Penetration Enhancers for Transdermal Gene and Drug Delivery","volume":"17","author":"Amjadi","year":"2017","journal-title":"Curr Gene Ther"},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/1574891X14666190717111531","article-title":"Nano-emulgel: Emerging as a Smarter Topical Lipidic Emulsion-based Nanocarrier for Skin Healthcare Applications","volume":"14","author":"Anand","year":"2019","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0035","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/02652048.2024.2423618","article-title":"Dermal drug delivery via bilosomes: a synergistic integration for better therapeutic outcomes","volume":"41","author":"Aralelimath","year":"2024","journal-title":"J. Microencapsul."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/biomedicines10020287","article-title":"CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications","volume":"10","author":"Arjomandnejad","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0045","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ajd.13096","article-title":"The efficacy and safety of tacrolimus as mono- and adjunctive therapy for vitiligo: A systematic review of randomised clinical trials","volume":"61","author":"Arora","year":"2020","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.34172\/apb.2021.011","article-title":"Preparation and Safety Evaluation of Topical Simvastatin Loaded NLCs for Vitiligo","volume":"11","author":"Ashtiani","year":"2021","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14649","article-title":"Evaluation of the effect of narrow band-ultraviolet B on the expression of tyrosinase, TYRP-1, and TYRP-2 mRNA in vitiligo skin and their correlations with clinical improvement: A retrospective study","volume":"34","author":"Awad","year":"2021","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.ijpx.2025.100397_bb0060","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fendo.2017.00290","article-title":"Vitiligo and Autoimmune Thyroid Disorders","volume":"8","author":"Baldini","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ijpx.2025.100397_bb0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2016.08.007","article-title":"The role of tight junctions in skin barrier function and dermal absorption","volume":"242","author":"B\u00e4sler","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2025.100397_bb0070","series-title":"The involvement of Smac\/DIABLO, p53, NF-kB, and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin","author":"Becatti","year":"2010"},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0075","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/pcmr.12219","article-title":"Type I interferon signature in the initiation of the immune response in vitiligo","volume":"27","author":"Bertolotti","year":"2014","journal-title":"Pigm. Cell Melanoma Res."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15321819.2024.2412528","article-title":"Emerging therapies and innovations in vitiligo management: a comprehensive review","volume":"46","author":"Bhange","year":"2025","journal-title":"J. Immunoass. Immunochem."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ijd.14766","article-title":"Expression of Th17- and Treg-specific transcription factors in vitiligo patients","volume":"59","author":"Bhardwaj","year":"2020","journal-title":"Int. J. Dermatol."},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb0090","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s40291-023-00672-z","article-title":"Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review","volume":"27","author":"Bia\u0142czyk","year":"2023","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.ijpx.2025.100397_bb0095","doi-asserted-by":"crossref","first-page":"1166135","DOI":"10.3389\/fimmu.2023.1166135","article-title":"Opportunities for Treg cell therapy for the treatment of human disease","volume":"14","author":"Bluestone","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613056","article-title":"Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective","volume":"12","author":"Boniface","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.ijpx.2025.100397_bb0105","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jid.2021.01.036","article-title":"Analysis of Matched Skin and Gut Microbiome of Patients with Vitiligo Reveals Deep Skin Dysbiosis: Link with Mitochondrial and Immune Changes","volume":"141","author":"Bzioueche","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41392-021-00830-x","article-title":"Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity","volume":"6","author":"Cao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ijpx.2025.100397_bb0115","doi-asserted-by":"crossref","first-page":"1197630","DOI":"10.3389\/fimmu.2023.1197630","article-title":"Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy","volume":"14","author":"Carbone","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0120","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/17512433.2022.2071699","article-title":"Efficacy of local prostaglandin analogues for vitiligo treatment: a systematic review and meta-analysis","volume":"15","author":"Chang","year":"2022","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb0125","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/cells12060936","article-title":"The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications","volume":"12","author":"Chang","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb0130","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jid.2017.01.020","article-title":"Simvastatin Protects Human Melanocytes from H2O2-Induced Oxidative Stress by Activating Nrf2","volume":"137","author":"Chang","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15596","article-title":"A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: A randomized, double-blind, placebo-controlled trial","volume":"35","author":"Charoenpongpun","year":"2022","journal-title":"Dermatol. Ther."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb0140","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/jid.2013.540","article-title":"A quantitative increase in regulatory T cells controls development of vitiligo","volume":"134","author":"Chatterjee","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.ijpx.2025.100397_bb0145","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1007\/s00210-023-02917-4","article-title":"Apigenin protects melanocytes and improves tyrosinase activity in a hydroquinone induced vitiligo mouse model targeting P38 MAP kinase signaling: histopathology and immunohistochemistry analysis","volume":"397","author":"Chauhan","year":"2024","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2019.05.011","article-title":"Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligo","volume":"139","author":"Chen","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijpx.2025.100397_bb0155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2019.05.011","article-title":"Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligo","volume":"139","author":"Chen","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.6073","article-title":"MIF inhibition alleviates vitiligo progression by suppressing CD8+ T cell activation and proliferation","volume":"260","author":"Chen","year":"2023","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jdermsci.2023.04.001","article-title":"Roflumilast enhances the melanogenesis and attenuates oxidative stress-triggered damage in melanocytes","volume":"110","author":"Chen","year":"2023","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0170","first-page":"37","article-title":"Research advances in smart responsive-hydrogel dressings with potential clinical diabetic wound healing properties","volume":"10","author":"Chen","year":"2023","journal-title":"Mil Med Res"},{"key":"10.1016\/j.ijpx.2025.100397_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118595","article-title":"Exploration of the mechanism of Qinglongyi-Buguzhi drug pair in treating vitiligo based on network pharmacology, molecular docking and experimental verification","volume":"334","author":"Chen","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jdermsci.2024.06.003","article-title":"Dysregulated tryptophan metabolism and AhR pathway contributed to CXCL10 upregulation in stable non-segmental vitiligo","volume":"115","author":"Chen","year":"2024","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/nano8010042","article-title":"Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis","volume":"8","author":"Chuang","year":"2018","journal-title":"Nanomaterials (Basel)"},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101385","article-title":"High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells","volume":"32","author":"Cochrane","year":"2024","journal-title":"Mol Ther Methods Clin Dev."},{"issue":"10","key":"10.1016\/j.ijpx.2025.100397_bb0200","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamadermatol.2015.1520","article-title":"Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy","volume":"151","author":"Craiglow","year":"2015","journal-title":"JAMA Dermatol."},{"issue":"13","key":"10.1016\/j.ijpx.2025.100397_bb0205","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.3390\/ijms25137236","article-title":"Exosomes Derived from Hypertrophic Scar Fibroblasts Suppress Melanogenesis in Normal Human Epidermal Melanocytes","volume":"25","author":"Cui","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0210","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jid.2019.08.435","article-title":"Antibiotics Drive Microbial Imbalance and Vitiligo Development in Mice","volume":"140","author":"Dellacecca","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0215","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.3390\/ijms24043357","article-title":"Current Status of Cell-Based Therapies for Vitiligo","volume":"24","author":"Domaszewska-Szostek","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2025.100397_bb0220","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jphotobiol.2017.07.007","article-title":"Development and in vitro assessment of psoralen and resveratrol co-loaded ultradeformable liposomes for the treatment of vitiligo","volume":"174","author":"Doppalapudi","year":"2017","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.ijpx.2025.100397_bb0225","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jphotobiol.2017.07.007","article-title":"Development and in vitro assessment of psoralen and resveratrol co-loaded ultradeformable liposomes for the treatment of vitiligo","volume":"174","author":"Doppalapudi","year":"2017","journal-title":"J. Photochem. Photobiol. B"},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1755-148X.2011.00942.x","article-title":"NLRP1, a regulator of innate immunity associated with vitiligo","volume":"25","author":"D\u2019Osualdo","year":"2012","journal-title":"Pigm. Cell Melanoma Res."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0235","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000536480","article-title":"Identification of TNF-\u03b1 as Major Susceptible Risk Locus for Vitiligo: A Systematic Review and Meta-Analysis Study in the Asian Population","volume":"240","author":"Dutta","year":"2024","journal-title":"Dermatology"},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0240","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/09546634.2020.1716930","article-title":"Combined microneedling with tacrolimus vs tacrolimus monotherapy for vitiligo treatment","volume":"32","author":"Ebrahim","year":"2021","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0245","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/09546634.2020.1716930","article-title":"Combined microneedling with tacrolimus vs tacrolimus monotherapy for vitiligo treatment","volume":"32","author":"Ebrahim","year":"2021","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb0250","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/jid.2015.26","article-title":"CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo","volume":"135","author":"Eby","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ijpx.2025.100397_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121523","article-title":"Novel berberine-loaded hyalurosomes as a promising nanodermatological treatment for vitiligo: Biochemical, biological and gene expression studies","volume":"615","author":"Elhalmoushy","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"21","key":"10.1016\/j.ijpx.2025.100397_bb0260","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.2174\/1381612829666230803111120","article-title":"Current State of Lipid Nanoparticles (SLN and NLC) for Skin Applications","volume":"29","author":"Ero\u011flu","year":"2023","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb0265","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40257-021-00631-6","article-title":"Psychosocial Effects of Vitiligo: A Systematic Literature Review","volume":"22","author":"Ezzedine","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/cei\/uxab002","article-title":"Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors","volume":"207","author":"Faraj","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118238","article-title":"Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis","volume":"268","author":"Fereig","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0280","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.3390\/ijerph19084812","article-title":"Surgical Treatment of Vitiligo","volume":"19","author":"Fr\u0105czek","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.ijpx.2025.100397_bb0285","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: Mechanisms of Pathogenesis and Treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0290","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: Mechanisms of Pathogenesis and Treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.ijpx.2025.100397_bb0295","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.tibtech.2019.12.009","article-title":"Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy","volume":"38","author":"Fritsche","year":"2020","journal-title":"Trends Biotechnol."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0300","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/1061186X.2015.1070855","article-title":"Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment","volume":"24","author":"Garg","year":"2016","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/1061186X.2015.1070855","article-title":"Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment","volume":"24","author":"Garg","year":"2016","journal-title":"J. Drug Target."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb0310","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00403-020-02068-z","article-title":"Tacrolimus (FK506) ointment combined with Nb-UVB could activate both hair follicle (HF) and dermal melanocyte precursors in vitiligo: the first histopathological and clinical study","volume":"313","author":"Gauthier","year":"2021","journal-title":"Arch. Dermatol. Res."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb0315","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ni.1718","article-title":"Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus","volume":"10","author":"Gebhardt","year":"2009","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0320","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/1872210516666220523121733","article-title":"A Detailed Insight into Nanostructured Lipid Carriers: A Versatile Drug Delivery System","volume":"17","author":"Ghosh","year":"2023","journal-title":"Recent Pat Nanotechnol"},{"key":"10.1016\/j.ijpx.2025.100397_bb0325","doi-asserted-by":"crossref","first-page":"6952299","DOI":"10.1155\/2022\/6952299","article-title":"Meta-Analysis of Alterations in Regulatory T Cells\u2019 Frequency and Suppressive Capacity in Patients with Vitiligo","volume":"2022","author":"Giri","year":"2022","journal-title":"J Immunol Res"},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0330","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jid.2024.08.005","article-title":"Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent Model","volume":"145","author":"Goldstein","year":"2025","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13167-025-00400-z","article-title":"Mitochondria in cutaneous health, disease, ageing and rejuvenation-the 3PM-guided mitochondria-centric dermatology","volume":"16","author":"Golubnitschaja","year":"2025","journal-title":"EPMA J."},{"issue":"9","key":"10.1016\/j.ijpx.2025.100397_bb0340","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3390\/ph16091270","article-title":"Tolerogenic Lipid Nanoparticles for Delivering Self-Antigen mRNA for the Treatment of Experimental Autoimmune Encephalomyelitis","volume":"16","author":"Gomi","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0345","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/pharmaceutics14030569","article-title":"Mixed Polymeric Micelles for Rapamycin Skin Delivery","volume":"14","author":"Guyader","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.ijpx.2025.100397_bb0350","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1111\/ijd.15330","article-title":"Simvastatin in vitiligo: an update with recent review of the literature","volume":"60","author":"Hasan","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0355","first-page":"92","article-title":"Study of the therapeutic effect of 8-methoxypsoralen liposome gel on leukodermia in guinea-pig model","volume":"16","author":"He","year":"2005","journal-title":"China Pharmacy"},{"key":"10.1016\/j.ijpx.2025.100397_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103057","article-title":"Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application","volume":"138","author":"Henschel","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ijpx.2025.100397_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122387","article-title":"The skin delivery of tofacitinib citrate using transethosomes and hybridized ethosomes\/nanostructured lipid carriers for vitiligo therapy: Dermatopharmacokinetics and in vivo assays","volume":"629","author":"Hesham","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0370","article-title":"Effects of CO2 fractional laser therapy on peripheral blood cytokines in patients with vitiligo","volume":"32","author":"Hu","year":"2019","journal-title":"Dermatol. Ther."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1720","article-title":"Melanocyte stem cells in the skin: Origin, biological characteristics, homeostatic maintenance and therapeutic potential","volume":"14","author":"Huang","year":"2024","journal-title":"Clin Transl Med"},{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1720","article-title":"Melanocyte stem cells in the skin: Origin, biological characteristics, homeostatic maintenance and therapeutic potential","volume":"14","author":"Huang","year":"2024","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.ijpx.2025.100397_bb0385","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2020.09.009","article-title":"Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval","volume":"156","author":"Hwang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0390","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jdermsci.2023.12.008","article-title":"JAK inhibitors for the treatment of vitiligo","volume":"113","author":"Inoue","year":"2024","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0395","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jdermsci.2023.12.008","article-title":"JAK inhibitors for the treatment of vitiligo","volume":"113","author":"Inoue","year":"2024","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0400","doi-asserted-by":"crossref","DOI":"10.1111\/srt.13642","article-title":"A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo","volume":"30","author":"Jafarzadeh","year":"2024","journal-title":"Skin Res. Technol."},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb0405","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4103\/ijd.ijd_865_22","article-title":"Comparison of Oral Azathioprine and Oral Mini Pulse Steroid in the Treatment of Vitiligo: An Open-Label Randomized Controlled Trial","volume":"68","author":"Jawade","year":"2023","journal-title":"Indian J. Dermatol."},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb0410","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4103\/ijd.ijd_865_22","article-title":"Comparison of Oral Azathioprine and Oral Mini Pulse Steroid in the Treatment of Vitiligo: An Open-Label Randomized Controlled Trial","volume":"68","author":"Jawade","year":"2023","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.123789","article-title":"Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy","volume":"364","author":"Jeong","year":"2025","journal-title":"Carbohydr. Polym."},{"issue":"7","key":"10.1016\/j.ijpx.2025.100397_bb0420","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/jcmm.12812","article-title":"Aspirin induces Nrf2-mediated transcriptional activation of haem oxygenase-1 in protection of human melanocytes from H2 O2-induced oxidative stress","volume":"20","author":"Jian","year":"2016","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0425","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00011-024-01900-w","article-title":"The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review","volume":"73","author":"Jin","year":"2024","journal-title":"Inflamm. Res."},{"issue":"61","key":"10.1016\/j.ijpx.2025.100397_bb0430","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1126\/sciimmunol.abe4723","article-title":"Unstable regulatory T cells, enriched for na\u00efve and Nrp1neg cells, are purged after fate challenge","volume":"6","author":"Junius","year":"2021","journal-title":"Sci Immunol."},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb0435","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/17425247.2019.1609449","article-title":"Polymeric micelle nanocarriers for targeted epidermal delivery of the hedgehog pathway inhibitor vismodegib: formulation development and cutaneous biodistribution in human skin","volume":"16","author":"Kandekar","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ijpx.2025.100397_bb0440","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.freeradbiomed.2018.08.022","article-title":"TRPM2 mediates mitochondria-dependent apoptosis of melanocytes under oxidative stress","volume":"126","author":"Kang","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0445","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14728214.2020.1712358","article-title":"Emerging drugs for the treatment of vitiligo","volume":"25","author":"Karagaiah","year":"2020","journal-title":"Expert Opin Emerg Drugs"},{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb0450","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1080\/13685538.2020.1806814","article-title":"Levels of TNF-\u03b1, IL-6, IL-17, IL-37 cytokines in patients with active vitiligo","volume":"23","author":"Karag\u00fcn","year":"2020","journal-title":"Aging Male"},{"issue":"12","key":"10.1016\/j.ijpx.2025.100397_bb0455","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1080\/17425247.2021.2011857","article-title":"Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis","volume":"18","author":"Katari","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"issue":"11","key":"10.1016\/j.ijpx.2025.100397_bb0460","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1111\/jdv.19019","article-title":"Mitochondria-Melanocyte cellular interactions: An emerging mechanism of vitiligo pathogenesis","volume":"37","author":"Kaushik","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0465","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jare.2021.06.014","article-title":"Skin cancer biology and barriers to treatment: Recent applications of polymeric micro\/nanostructures","volume":"36","author":"Khan","year":"2021","journal-title":"J. Adv. Res."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0470","article-title":"Clinical evaluation of the efficacy of trichloroacetic acid 70% after microneedling vs intradermal injection of 5-fluorouracil in the treatment of nonsegmental vitiligo","volume":"33","author":"Khater","year":"2020","journal-title":"A prospective comparative study. Dermatol Ther"},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb0475","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17425247.2020.1713087","article-title":"Permeation enhancers in transdermal drug delivery: benefits and limitations","volume":"17","author":"Kov\u00e1\u010dik","year":"2020","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0480","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1468-3083.2006.01420.x","article-title":"Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo","volume":"20","author":"Kumaran","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"9","key":"10.1016\/j.ijpx.2025.100397_bb0485","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1021\/mp400639e","article-title":"Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis","volume":"11","author":"Lapteva","year":"2014","journal-title":"Mol. Pharm."},{"issue":"17","key":"10.1016\/j.ijpx.2025.100397_bb0490","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.3390\/ijms241713313","article-title":"Challenges and Future Trends in the Treatment of Psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"32","key":"10.1016\/j.ijpx.2025.100397_bb0495","doi-asserted-by":"crossref","first-page":"36331","DOI":"10.1021\/acsami.2c07135","article-title":"Skin Penetration Enhancer-Incorporated Lipid Nanovesicles (SPE-LNV) for Skin Brightening and Wrinkle Treatment","volume":"14","author":"Lee","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb0500","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/ajd.14001","article-title":"A review of JAK and IL-23 inhibitors to treat vitiligo","volume":"64","author":"Lee","year":"2023","journal-title":"Australas J Dermatol"},{"issue":"5\u20136","key":"10.1016\/j.ijpx.2025.100397_bb0505","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s12026-016-8809-7","article-title":"Evaluation of serum immunoglobulins concentrations and distributions in vitiligo patients","volume":"64","author":"Li","year":"2016","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0510","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaci.2016.10.013","article-title":"Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes","volume":"140","author":"Li","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0515","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaci.2016.10.013","article-title":"Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes","volume":"140","author":"Li","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0520","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaci.2016.10.013","article-title":"Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes","volume":"140","author":"Li","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.ijpx.2025.100397_bb0525","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.jid.2022.05.1086","article-title":"Circulating Exosomal miR-493-3p Affects Melanocyte Survival and Function by Regulating Epidermal Dopamine Concentration in Segmental Vitiligo","volume":"142","author":"Li","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ijpx.2025.100397_bb0530","doi-asserted-by":"crossref","first-page":"1419660","DOI":"10.3389\/fimmu.2024.1419660","article-title":"Exosome-derived microRNAs: emerging players in vitiligo","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0535","doi-asserted-by":"crossref","first-page":"1291556","DOI":"10.3389\/fimmu.2024.1291556","article-title":"The role of aryl hydrocarbon receptor in vitiligo: a review","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0540","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12951-025-03119-1","article-title":"Biomimetic polydopamine loaded with janus kinase inhibitor for synergistic vitiligo therapy via hydrogel microneedles","volume":"23","author":"Li","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.ijpx.2025.100397_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120549","article-title":"Tofacitinib combined with melanocyte protector \u03b1-MSH to treat vitiligo through dextran based hydrogel microneedles","volume":"305","author":"Liang","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpx.2025.100397_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108670","article-title":"Nuclear factor erythroid 2-related factor 2 (Nrf2) as a potential therapeutic target for vitiligo","volume":"696","author":"Lin","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"issue":"11","key":"10.1016\/j.ijpx.2025.100397_bb0555","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/jdv.19022","article-title":"The possible role of Wnt\/\u03b2-catenin signalling in vitiligo treatment","volume":"37","author":"Lin","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0560","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14856","article-title":"The underestimated role of mitochondria in vitiligo: From oxidative stress to inflammation and cell death","volume":"33","author":"Lin","year":"2024","journal-title":"Exp. Dermatol."},{"issue":"12","key":"10.1016\/j.ijpx.2025.100397_bb0565","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1111\/jocd.15833","article-title":"Clinical effect of stem cell transplantation combined with 308-nm excimer laser therapy for 56 cases of vitiligo","volume":"22","author":"Liu","year":"2023","journal-title":"J. Cosmet. Dermatol."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0570","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000288166","article-title":"Epidermal permeability barrier recovery is delayed in vitiligo-involved sites","volume":"23","author":"Liu","year":"2010","journal-title":"Skin Pharmacol. Physiol."},{"issue":"45","key":"10.1016\/j.ijpx.2025.100397_bb0575","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201804788","article-title":"Lipid Nanovesicles by Microfluidics: Manipulation, Synthesis, and Drug Delivery","volume":"31","author":"Liu","year":"2019","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0580","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250281","article-title":"The IFN-\u03b3-CXCL9\/CXCL10-CXCR3 axis in vitiligo: Pathological mechanism and treatment","volume":"54","author":"Liu","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0585","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cytogfr.2024.11.002","article-title":"JAK inhibitors in immune regulation and treatment of vitiligo","volume":"80","author":"Liu","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ijpx.2025.100397_bb0590","doi-asserted-by":"crossref","first-page":"1378359","DOI":"10.3389\/fimmu.2024.1378359","article-title":"Heterogeneity and plasticity of tissue-resident memory T cells in skin diseases and homeostasis: a review","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0595","doi-asserted-by":"crossref","first-page":"1468665","DOI":"10.3389\/fimmu.2025.1468665","article-title":"Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0600","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jddst.2019.02.033","article-title":"Edge activated ultradeformable liposomes of psoralen and its derivatives: development and comparative evaluation for vitiligo therapy","volume":"52","author":"Mahira","year":"2019","journal-title":"J Drug Deliv Sci Tec"},{"key":"10.1016\/j.ijpx.2025.100397_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121459","article-title":"Photodynamic therapy fortified with topical oleyl alcohol-based transethosomal 8-methoxypsoralen for ameliorating vitiligo: Optimization and clinical study","volume":"614","author":"Mahmoud","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0610","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1002\/jps.22104","article-title":"Enhancement of transdermal absorption, gene expression and stability of tyrosinase plasmid (pMEL34)-loaded elastic cationic niosomes: potential application in vitiligo treatment","volume":"99","author":"Manosroi","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2025.100397_bb0615","doi-asserted-by":"crossref","DOI":"10.34172\/jlms.2024.38","article-title":"Fractional CO2 Laser Versus Microneedling Combined with Narrowband Ultraviolet and Topical Steroid for Treating Non-Segmental Vitiligo in Treatment-Resistant Localizations: A Comparative Randomized Clinical Trial Study","volume":"15","author":"Mansouri","year":"2024","journal-title":"J Lasers Med Sci"},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0620","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/phpp.12740","article-title":"UVB phototherapy in the treatment of vitiligo: State of the art and clinical perspectives","volume":"38","author":"Mendes","year":"2022","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.ijpx.2025.100397_bb0625","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.colsurfb.2018.12.055","article-title":"Baicalin and berberine ultradeformable vesicles as potential adjuvant in vitiligo therapy","volume":"175","author":"Mir-Palomo","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0630","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/bjd.18606","article-title":"Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo","volume":"182","author":"Mobasher","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0635","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/09546634.2020.1810202","article-title":"Factors affecting vitiligo response to treatment: do MiRNA 196a2C\/T gene polymorphism and serum tyrosinase levels have any role?","volume":"33","author":"Monib","year":"2022","journal-title":"J Dermatolog Treat"},{"issue":"174","key":"10.1016\/j.ijpx.2025.100397_bb0640","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1126\/scitranslmed.3005127","article-title":"Mutant HSP70 reverses autoimmune depigmentation in vitiligo","volume":"5","author":"Mosenson","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.ijpx.2025.100397_bb0645","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3390\/cells12111534","article-title":"CAR-Based Therapy for Autoimmune Diseases: A Novel Powerful Option","volume":"12","author":"M\u0171zes","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0650","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jdermsci.2023.04.006","article-title":"Targeting the elevated IFN-\u03b3 in vitiligo patients by human anti-IFN-\u03b3 monoclonal antibody hampers direct cytotoxicity in melanocyte","volume":"110","author":"Ng","year":"2023","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0655","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00403-024-03679-6","article-title":"Vitiligo and the microbiome of the gut and skin: a systematic review","volume":"317","author":"Nigro","year":"2025","journal-title":"Arch. Dermatol. Res."},{"issue":"10","key":"10.1016\/j.ijpx.2025.100397_bb0660","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1111\/jocd.14987","article-title":"Combination of epidermal keratinocyte-melanocyte cells suspension and microneedling: Safe surgical approach in vitiligo","volume":"21","author":"Nilforoushzadeh","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0665","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/molecules22081303","article-title":"Upregulation of Melanogenesis and Tyrosinase Activity: Potential Agents for Vitiligo","volume":"22","author":"Niu","year":"2017","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.ijpx.2025.100397_bb0670","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1016\/j.bmc.2016.08.066","article-title":"Synthesis and bioactivity of novel isoxazole chalcone derivatives on tyrosinase and melanin synthesis in murine B16 cells for the treatment of vitiligo","volume":"24","author":"Niu","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0675","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15294","article-title":"Microneedling combined with pimecrolimus, 5-fluorouracil, and trichloroacetic acid in the treatment of vitiligo: A comparative study","volume":"35","author":"Nofal","year":"2022","journal-title":"Dermatol. Ther."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0680","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/bjd.19661","article-title":"Classification of facial and truncal segmental vitiligo and its clinical courses including recurrence rate and patterns: a retrospective review of 956 patients","volume":"184","author":"Oh","year":"2021","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0685","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/pde.14159","article-title":"Tofacitinib cream plus narrowband ultraviolet B phototherapy for segmental vitiligo in a child","volume":"37","author":"Olamiju","year":"2020","journal-title":"Pediatr. Dermatol."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0690","first-page":"2933","article-title":"MMP-sensitive PEG hydrogel modified with RGD promotes bFGF, VEGF and EPC-mediated angiogenesis","volume":"18","author":"Ouyang","year":"2019","journal-title":"Exp Ther Med."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0695","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/03639045.2022.2100901","article-title":"Development of piperine nanoemulsions: an alternative topical application for hypopigmentation","volume":"48","author":"Ozkan","year":"2022","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb0700","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"16","key":"10.1016\/j.ijpx.2025.100397_bb0705","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa1607017","article-title":"Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis","volume":"376","author":"Papp","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb0710","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1567201811666140515145329","article-title":"Physical means of stratum corneum barrier manipulation to enhance transdermal drug delivery","volume":"12","author":"Parhi","year":"2015","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.ijpx.2025.100397_bb0715","doi-asserted-by":"crossref","unstructured":"Parsad D, Kanwar A. (2010). Oral minocycline in the treatment of vitiligo--a preliminary study. Dermatol. Ther. 23(3):305-7.","DOI":"10.1111\/j.1529-8019.2010.01328.x"},{"key":"10.1016\/j.ijpx.2025.100397_bb0720","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.colsurfb.2012.08.011","article-title":"Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: ex vivo permeation and skin irritation studies","volume":"102","author":"Patel","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"24","key":"10.1016\/j.ijpx.2025.100397_bb0725","doi-asserted-by":"crossref","first-page":"17306","DOI":"10.3390\/ijms242417306","article-title":"Vitiligo: Pathogenesis and New and Emerging Treatments","volume":"24","author":"Perez-Bootello","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2025.100397_bb0730","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2022.09.025","article-title":"Overcoming skin barriers through advanced transdermal drug delivery approaches","volume":"351","author":"Phatale","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2025.100397_bb0735","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-030-88071-2_4","article-title":"Dermal Delivery of Lipid Nanoparticles: Effects on Skin and Assessment of Absorption and Safety","volume":"1357","author":"Pinto","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb0740","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5114\/ada.2024.138818","article-title":"Afamelanotide in protoporphyria and other skin diseases: a review","volume":"41","author":"Pola\u0144ska","year":"2024","journal-title":"Postepy Dermatol. Alergol."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb0745","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/pcmr.13101","article-title":"Trained immunity in the pathogenesis of vitiligo","volume":"36","author":"Post","year":"2023","journal-title":"Pigm. Cell Melanoma Res."},{"issue":"11","key":"10.1016\/j.ijpx.2025.100397_bb0750","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1111\/jocd.16468","article-title":"Utility of prostaglandin analogues and phosphodiesterase inhibitors as promising last resorts for the treatment of vitiligo: A systematic review, from mechanisms of action to mono-, combination and comparative therapies","volume":"23","author":"Pourriyahi","year":"2024","journal-title":"J. Cosmet. Dermatol."},{"issue":"11","key":"10.1016\/j.ijpx.2025.100397_bb0755","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1111\/jocd.15158","article-title":"Drug delivery of natural products through nano-carriers for effective vitiligo therapy: A compendia review","volume":"21","author":"Qadir","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0760","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790125","article-title":"Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review","volume":"12","author":"Qi","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0765","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/jid.2014.241","article-title":"Oxidative stress and vitiligo: the Nrf2-ARE signaling connection","volume":"134","author":"Qiu","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.ijpx.2025.100397_bb0770","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.7150\/thno.69999","article-title":"Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment","volume":"12","author":"Qu","year":"2022","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb0775","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1208\/s12249-023-02564-1","article-title":"Dapsone-Loaded Mixed Micellar Gel for Treatment OF Acne Vulgaris","volume":"24","author":"Rao","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"223","key":"10.1016\/j.ijpx.2025.100397_bb0780","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijpx.2025.100397_bb0785","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","author":"Rashighi","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"24","key":"10.1016\/j.ijpx.2025.100397_bb0790","doi-asserted-by":"crossref","first-page":"15980","DOI":"10.3390\/ijms232415980","article-title":"Nanoparticles for Topical Application in the Treatment of Skin Dysfunctions-An Overview of Dermo-Cosmetic and Dermatological Products","volume":"23","author":"Raszewska-Famielec","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.ijpx.2025.100397_bb0795","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.jid.2023.03.1689","article-title":"Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte-Keratinocyte Transplantation Surgery for Vitiligo","volume":"143","author":"Refat","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0800","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jamadermatol.2024.0021","article-title":"Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients","volume":"160","author":"Renert-Yuval","year":"2024","journal-title":"JAMA Dermatol."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0805","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jid.2016.10.048","article-title":"CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice","volume":"137","author":"Richmond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ijpx.2025.100397_bb0810","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","author":"Richmond","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0815","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.1900027","article-title":"The Role of Memory CD8+ T Cells in Vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0825","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4161\/derm.19200","article-title":"When are laboratory tests indicated in patients with vitiligo?","volume":"4","author":"Rodr\u00edguez-Mart\u00edn","year":"2012","journal-title":"Dermatoendocrinol"},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0830","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3892\/etm.2021.9743","article-title":"Novel immunological and genetic factors associated with vitiligo: A review","volume":"21","author":"Said-Fernandez","year":"2021","journal-title":"Exp Ther Med"},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb0835","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/jsde.12698","article-title":"Design and characterization of dual-pronged liposome-embedded gel for enhanced dermal delivery","volume":"26","author":"Saxena","year":"2023","journal-title":"J. Surfactant Deterg."},{"issue":"15","key":"10.1016\/j.ijpx.2025.100397_bb0840","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.3390\/ijms23158272","article-title":"Regulation of CD4+ and CD8+ T Cell Biology by Short-Chain Fatty Acids and Its Relevance for Autoimmune Pathology","volume":"23","author":"Schiweck","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0845","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00105-024-05467-9","article-title":"Vitiligo-update on pathogenesis, diagnostics and therapy","volume":"76","author":"Seidel","year":"2025","journal-title":"Dermatologie (Heidelb)"},{"issue":"11","key":"10.1016\/j.ijpx.2025.100397_bb0850","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/jdv.19450","article-title":"Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations","volume":"37","author":"Seneschal","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102868","article-title":"Emerging role of Tissue Resident Memory T cells in vitiligo: From pathogenesis to therapeutics","volume":"20","author":"Shah","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0860","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14982","article-title":"Compromised melanocyte survival due to decreased suppression of CD4+ & CD8+ resident memory T cells by impaired TRM-regulatory T cells in generalized vitiligo patients","volume":"33","author":"Shah","year":"2024","journal-title":"Exp. Dermatol."},{"issue":"12","key":"10.1016\/j.ijpx.2025.100397_bb0865","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15969","article-title":"Simvastatin and non-segmental vitiligo: A new potential treatment option?","volume":"35","author":"Shaker","year":"2022","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.ijpx.2025.100397_bb0870","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ijbiomac.2020.06.110","article-title":"RETRACTED: A review on biomacromolecular hydrogel classification and its applications","volume":"162","author":"Sharma","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0875","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.autrev.2016.01.004","article-title":"The role of IL-17 in vitiligo: A review","volume":"15","author":"Singh","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ijpx.2025.100397_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155432","article-title":"Tumor Necrosis Factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo","volume":"140","author":"Singh","year":"2021","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0885","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/bioengineering9040158","article-title":"Microemulsions and Nanoemulsions in Skin Drug Delivery","volume":"9","author":"Souto","year":"2022","journal-title":"Bioengineering (Basel)"},{"issue":"36","key":"10.1016\/j.ijpx.2025.100397_bb0890","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.2174\/1381612826666200417144530","article-title":"Lipid Nanoparticles as a Skin Wound Healing Drug Delivery System: Discoveries and Advances","volume":"26","author":"Souza","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"11","key":"10.1016\/j.ijpx.2025.100397_bb0895","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1111\/jdv.19400","article-title":"The real-life efficacy of methotrexate in vitiligo: A retrospective study and literature review","volume":"37","author":"Speeckaert","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0900","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2174\/1566524022666220621125552","article-title":"Melanocyte Adhesion and Apoptosis in Vitiligo: Linking Puzzle Blocks","volume":"23","author":"Srivastava","year":"2023","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ijpx.2025.100397_bb0905","doi-asserted-by":"crossref","first-page":"1077681","DOI":"10.3389\/fimmu.2022.1077681","article-title":"Anti-IL-17A antibody-associated de novo vitiligo: Case report and review of literature","volume":"13","author":"Su","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0910","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/09546634.2014.991268","article-title":"Treatment of 308-nm excimer laser on vitiligo: A systemic review of randomized controlled trials","volume":"26","author":"Sun","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ijpx.2025.100397_bb0915","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2147\/IJN.S245326","article-title":"Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo","volume":"15","author":"Sun","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"11","key":"10.1016\/j.ijpx.2025.100397_bb0920","doi-asserted-by":"crossref","first-page":"17361","DOI":"10.1021\/acsnano.1c05321","article-title":"Biomimetic Melanosomes Promote Orientation-Selective Delivery and Melanocyte Pigmentation in the H2O2-Induced Vitiligo Mouse Model","volume":"15","author":"Sun","year":"2021","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb0925","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/bjd\/ljac092","article-title":"Successful treatment of vitiligo with crisaborole ointment: a report of two cases","volume":"188","author":"Sun","year":"2023","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb0930","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s10103-024-04033-y","article-title":"308 nm excimer laser and tacrolimus ointment in the treatment of facial vitiligo: a systematic review and meta-analysis","volume":"39","author":"Suo","year":"2024","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.ijpx.2025.100397_bb0935","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jdcr.2021.03.028","article-title":"Repigmentation in a patient with vitiligo on crisaborole 2% ointment","volume":"11","author":"Tam","year":"2021","journal-title":"JAAD Case Rep."},{"issue":"12","key":"10.1016\/j.ijpx.2025.100397_bb0940","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/s41374-018-0126-4","article-title":"Vitamin D protects human melanocytes against oxidative damage by activation of Wnt\/\u03b2-catenin signaling","volume":"98","author":"Tang","year":"2018","journal-title":"Lab. Investig."},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb0945","first-page":"696","article-title":"Prevalence of depression and anxiety among adults with vitiligo in a Malaysian tertiary hospital","volume":"78","author":"Ting","year":"2023","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.ijpx.2025.100397_bb0950","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.618897","article-title":"Pathophysiology of Skin Resident Memory T Cells","volume":"11","author":"Tokura","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb0955","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41385-022-00524-9","article-title":"Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation","volume":"15","author":"Trompette","year":"2022","journal-title":"Mucosal Immunol."},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb0960","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/jid.2011.16","article-title":"Skin-Depigmenting Agent Monobenzone Induces Potent T-Cell Autoimmunity toward Pigmented Cells by Tyrosinase Haptenation and Melanosome Autophagy","volume":"131","author":"van den Boorn","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijpx.2025.100397_bb0965","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","article-title":"Microneedles: A smart approach and increasing potential for transdermal drug delivery system","volume":"109","author":"Waghule","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"36","key":"10.1016\/j.ijpx.2025.100397_bb0970","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.2174\/1381612826666200614175236","article-title":"Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin Disorders","volume":"26","author":"Waghule","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"31","key":"10.1016\/j.ijpx.2025.100397_bb0975","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"3D-hUMSCs Exosomes Ameliorate Vitiligo by Simultaneously Potentiating Treg Cells-Mediated Immunosuppression and Suppressing Oxidative Stress-Induced Melanocyte Damage","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"31","key":"10.1016\/j.ijpx.2025.100397_bb0980","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"3D-hUMSCs Exosomes Ameliorate Vitiligo by Simultaneously Potentiating Treg Cells-Mediated Immunosuppression and Suppressing Oxidative Stress-Induced Melanocyte Damage","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)."},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb0985","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jid.2024.02.007","article-title":"Emerging Role of Fibroblasts in Vitiligo: A Formerly Underestimated Rising Star","volume":"144","author":"Wu","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ijpx.2025.100397_bb0990","doi-asserted-by":"crossref","first-page":"1521097","DOI":"10.3389\/fphar.2025.1521097","article-title":"Galangin ameliorates PTU-induced vitiligo in zebrafish and B16F10 cells by increasing melanogenesis through activation of the p38\/JNK MAPK pathway","volume":"16","author":"Wusiman","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb0995","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/09546634.2014.952610","article-title":"Treatment of vitiligo with NB-UVB: A systematic review","volume":"26","author":"Xiao","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ijpx.2025.100397_bb1000","doi-asserted-by":"crossref","first-page":"1083432","DOI":"10.3389\/fmicb.2022.1083432","article-title":"The role of short-chain fatty acids in inflammatory skin diseases","volume":"13","author":"Xiao","year":"2023","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb1005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.09.003","article-title":"Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?","volume":"81","author":"Xie","year":"2016","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100397_bb1010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14728222.2023.2193329","article-title":"Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection","volume":"27","author":"Xie","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ijpx.2025.100397_bb1015","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2147\/CCID.S459070","article-title":"Endoplasmic Reticulum Dysfunction: An Emerging Mechanism of Vitiligo Pathogenesis","volume":"17","author":"Xie","year":"2024","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"10","key":"10.1016\/j.ijpx.2025.100397_bb1020","first-page":"52","article-title":"The effect of combined calcipotriol and betamethasone dipropionate ointment in the treatment of vitiligo: an open, uncontrolled trial","volume":"11","author":"Xing","year":"2012","journal-title":"J. Drugs Dermatol."},{"issue":"7891","key":"10.1016\/j.ijpx.2025.100397_bb1025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","article-title":"Anatomically distinct fibroblast subsets determine skin autoimmune patterns","volume":"601","author":"Xu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ijpx.2025.100397_bb1030","doi-asserted-by":"crossref","first-page":"7197533","DOI":"10.1155\/2022\/7197533","article-title":"Mechanism of Action of a Chinese Herbal Compound Containing Quercetin, Luteolin, and Kaempferol in the Treatment of Vitiligo Based on Network Pharmacology and Experimental Verification","volume":"2022","author":"Xu","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb1035","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/jocd.15637","article-title":"Recurrence and risk factors in cured patients with vitiligo: A real-life single-center retrospective study","volume":"22","author":"Xu","year":"2023","journal-title":"J. Cosmet. Dermatol."},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb1040","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.3390\/ijms25084409","article-title":"Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences","volume":"25","author":"Yamaguchi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ijpx.2025.100397_bb1045","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.3390\/ijms25084409","article-title":"Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences","volume":"25","author":"Yamaguchi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb1050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/ijms22010269","article-title":"Local Epidermal Endocrine Estrogen Protects Human Melanocytes against Oxidative Stress, a Novel Insight into Vitiligo Pathology","volume":"22","author":"Yamamoto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2025.100397_bb1055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actbio.2020.12.004","article-title":"Microneedle-mediated transdermal drug delivery for treating diverse skin diseases","volume":"121","author":"Yang","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2025.100397_bb1060","doi-asserted-by":"crossref","first-page":"1293101","DOI":"10.3389\/fcell.2023.1293101","article-title":"Antioxidant mechanisms of mesenchymal stem cells and their therapeutic potential in vitiligo","volume":"11","author":"Yang","year":"2023","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb1065","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/exd.14260","article-title":"Skin pigmentation and its control: From ultraviolet radiation to stem cells","volume":"30","author":"Yardman-Frank","year":"2021","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb1070","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14669","article-title":"Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review","volume":"34","author":"Yazdanian","year":"2021","journal-title":"Dermatol. Ther."},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb1075","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.7150\/thno.30398","article-title":"SIRT3-Dependent Mitochondrial Dynamics Remodeling Contributes to Oxidative Stress-Induced Melanocyte Degeneration in Vitiligo","volume":"9","author":"Yi","year":"2019","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.ijpx.2025.100397_bb1080","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/1346-8138.16680","article-title":"Melanocyte-specific CD49a+ CD8+ T cells in vitiligo lesion potentiate to maintain activity during systemic steroid therapy","volume":"50","author":"Yokoi","year":"2023","journal-title":"J. Dermatol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb1085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00403-023-02761-9","article-title":"Practical guidelines for the treatment of vitiligo with the melanocyte-keratinocyte transplantation procedure","volume":"316","author":"Yousif","year":"2023","journal-title":"Arch. Dermatol. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ijpx.2025.100397_bb1090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/exd.13823","article-title":"Mechanisms of repigmentation induced by photobiomodulation therapy in vitiligo","volume":"28","author":"Yu","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijpx.2025.100397_bb1095","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.964982","article-title":"MicroRNAs: Emerging players in the pathogenesis of vitiligo","volume":"10","author":"Yu","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.ijpx.2025.100397_bb1100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.14715\/cmb\/2024.70.4.23","article-title":"Research progress of vitiligo repigmentation: from oxidative stress to autoimmunity","volume":"70","author":"Yu","year":"2024","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb1105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/jid.2013.268","article-title":"Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes","volume":"134","author":"Zhang","year":"2014","journal-title":"J Invest Dermatol."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb1110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jdermsci.2018.12.005","article-title":"Circulating CCL20: A potential biomarker for active vitiligo together with the number of Th1\/17 cells","volume":"93","author":"Zhang","year":"2019","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.ijpx.2025.100397_bb1115","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/09546634.2019.1687825","article-title":"The effects of 308-nm excimer laser on the infiltration of CD4+, CD8+ T-cells, and regulatory T cells in the lesional skin of patients at active and stable stages of nonsegmental vitiligo","volume":"32","author":"Zhang","year":"2021","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb1120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/jim-2020-001390","article-title":"Efficacy and safety of oral simvastatin in the treatment of patients with vitiligo","volume":"69","author":"Zhang","year":"2021","journal-title":"J. Investig. Med."},{"issue":"7","key":"10.1016\/j.ijpx.2025.100397_bb1125","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1080\/21645515.2021.1872342","article-title":"Polymeric nanoparticles containing rapamycin and autoantigen induce antigen-specific immunological tolerance for preventing vitiligo in mice","volume":"17","author":"Zhang","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"issue":"20","key":"10.1016\/j.ijpx.2025.100397_bb1130","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1111\/jcmm.15864","article-title":"Down-regulation of exosomal miR-200c derived from keratinocytes in vitiligo lesions suppresses melanogenesis","volume":"24","author":"Zhao","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijpx.2025.100397_bb1135","article-title":"Injectable crosslinked HA hydrogel: a promising carrier for cell transplantation to treat stable vitiligo","author":"Zheng","year":"2025","journal-title":"Front. Med."},{"issue":"9","key":"10.1016\/j.ijpx.2025.100397_bb1140","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1096\/fj.201701242RR","article-title":"IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo","volume":"32","author":"Zhou","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.ijpx.2025.100397_bb1145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jtcms.2025.03.008","article-title":"Delivery of Sophora flavescens Ait. using a dissolving microneedle enables enhanced psoriasis treatment","volume":"12","author":"Zhou","year":"2025","journal-title":"Journal of Traditional Chinese Medical Sciences."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100397_bb1150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/07853890.2019.1592215","article-title":"The role of exosome in autoimmune connective tissue disease","volume":"51","author":"Zhu","year":"2019","journal-title":"Ann. Med."},{"issue":"9","key":"10.1016\/j.ijpx.2025.100397_bb1155","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1021\/acsnano.3c01960","article-title":"MC1R Peptide Agonist Self-Assembles into a Hydrogel That Promotes Skin Pigmentation for Treating Vitiligo","volume":"17","author":"Zhu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2025.100397_bb1160","doi-asserted-by":"crossref","first-page":"6732972","DOI":"10.1155\/2022\/6732972","article-title":"Occludin Promotes Adhesion of CD8+ T Cells and Melanocytes in Vitiligo via the HIF-1 \u03b1 Signaling Pathway","volume":"2022","author":"Zou","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100397_bb1165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.det.2019.08.005","article-title":"Phototherapy for Vitiligo","volume":"38","author":"Zubair","year":"2020","journal-title":"Dermatol. Clin."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156725000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156725000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:57:37Z","timestamp":1765933057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156725000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":233,"alternative-id":["S2590156725000829"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2025.100397","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"recent advances in the pathogenesis of vitiligo and the application of novel drug delivery systems in its treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2025.100397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100397"}}